Objective: Exercise-associated muscle cramping (EAMC) is a common medical condition in endurance athletes. The exact cause of and risk factors for EAMC are still being investigated. The main objective of this study was to investigate factors that are associated with a self-reported history of EAMC in Ironman triathletes.
INTRODUCTION
The Ironman Triathlon consists of a 3.8 km swim, a 180 km cycle, and a 42.2 km run. Medical conditions commonly occur during training or competition in the Ironman Triathlon. 1 One of the most common medical conditions that Ironman triathletes suffer from is ''exercise-associated muscle cramps'' (EAMC), 1,2 which can be defined as ''painful, spasmodic, involuntary contraction of skeletal muscle that occurs during or immediately after exercise.'' 3 Clinically, EAMC presents as painful spasmodic muscle cramps, localized to exercising muscle groups. 4 Intrinsic and extrinsic risk factors associated with EAMC have been the topic of scientific debate over the years, and these have recently been reviewed. 4, 5 Traditional risk factors for the development of EAMC are a combination of extreme environmental heat and humidity, dehydration and electrolyte disturbances, in particular sodium depletion. It is still assumed that dehydration and sodium depletion are the main etiological factors in the development of EAMC, [5] [6] [7] [8] [9] despite the fact that evidence for these risk factors is weak. 10 The ''altered neuromuscular control'' hypothesis is an alternative hypothesis for the development of EAMC 3, 4, [10] [11] [12] and is based on evidence from clinical observations and experimental studies (animal and human), which suggest that the development of muscular fatigue, and other factors, can lead to abnormal neuromuscular control in the skeletal muscle. 10 It is, however, clear that further research is required to determine the risk factors for EAMC in athletes. One model to determine which risk factors may be associated with EAMC is to study endurance athletes who have never suffered from EAMC and compare them with those who have a history of EAMC. The Ironman Triathlon is an ideal field setting to study because EAMC is particularly common in this event and many triathletes have a history of EAMC. Studies undertaken in these triathletes could lead to a further understanding of the factors that are associated with EAMC in endurance athletes. To our knowledge, a large descriptive study of this nature in a group of endurance athletes has not been undertaken.
The aim of this study was to investigate factors that are associated with a self-reported history of EAMC in triathletes participating in an Ironman Triathlon. Study procedures, informed consent forms, questionnaires, and contact details for questions were posted on the official race Web site before the study. Recruitment of subjects for the study began during the 3-day race registration period before the events.
METHODS

Subjects
PreRace Questionnaire
For the purpose of this study, a previously validated prerace questionnaire was modified and used. 2, 13, 14 After giving written informed consent, subjects were encouraged to complete the prerace questionnaire while remaining in the research area (.90% complied with this request). All subjects returned the questionnaire before the race day.
This prerace questionnaire consisted of various sections and included (1) personal particulars, (2) family history and personal medical history, and (3) training and racing histories. Information from the following sections was used: (1) demographic details (including age, height, weight, and sex), (2) participation history in distance running (10, 21.1, and 42.2 km) and triathlon events [including personal best (PB) times], (3) training details in the 15 weeks before the actual event (training distances and hours spent training), (4) frequency of flexibility training and stretching exercises, (5) family history of EAMC, and (6) personal general medical history, including a history of EAMC.
More specific training (number of fast/hard swimming, cycling, and running training sessions during the 8 weeks before the triathlon) and racing (PB times in a cycling race between 80 and 100 km during the 15 weeks before the triathlon) questions were included in the 2007 questionnaire and were therefore analyzed only in the subgroup of athletes from the 2007 Ironman.
If a triathlete answered positively to a specific question related to EAMC: ''Have you ever in your triathlon career suffered from muscle cramping during or immediately after exercise,'' they were then requested to complete a further detailed section of the prerace questionnaire.
In this detailed ''cramping section'' of the questionnaire, the triathletes were asked to report history of EAMC including the following: (1) for how many years they had been experiencing EAMC; (2) if the cramping occurred before, during or after their exercise, during which event (swimming, cycling, or running) the cramping occurred; (3) which muscles were affected during the cramping event; (4) at what point during training or racing did the EAMC occur; (5) if they had had any severe complications from cramping that necessitated medical intervention, how severe the episodes were perceived to be; and (6) However, 5 triathletes did not answer the specific question related to EAMC: ''Have you ever in your triathlon career suffered from muscle cramping during or immediately after exercise'' and were therefore excluded from this study. Thus, 433 subjects were finally included in this study: 216 with a history of EAMC (EAMC group) and 217 with no history of EAMC (CON group).
Statistical Analysis of Data
All the data from the questionnaire were entered onto an Excel spreadsheet (Microsoft Office 2003, Microsoft Corporation, Redmond, Washington) and then analyzed using the Statistica 8.0 statistical program (StatSoft, Inc, Tulsa, Oklahoma). All numerical data are represented by the mean 6 SD, with the number of subjects (n) being represented in parenthesis. A 1-way analysis of variance was used to determine any significant differences between the groups. Categorical data were analyzed using the x 2 test, and statistical significance was accepted with a P , 0.05.
RESULTS
Subject and Cramping Characteristics
There were no significant differences in age, BMI, or any occupational variables between the 2 groups (Table 1) . There were, however, significantly more men (P = 0.011) in the EAMC group. Triathletes in the EAMC group were also significantly taller (P , 0.001) and heavier (P = 0.003) than those in the CON group. This difference in height remained even when covaried for sex (P = 0.007).
Triathletes in the EAMC group reported an average history of EAMC more than 7.3 6 8.6 years (n = 145). Of the triathletes, 76% (155 of 202) reported EAMC during or immediately after exercise during the 12 months before the triathlon. Cramping was associated with swimming, cycling, and running in 92 (45.5%), 106 (52.4%), and 116 (57.4%) of the triathletes, respectively. The majority of triathletes reported experiencing EAMC within the last quarter (n = 108, 56.0%) or immediately after (n = 50, 25.9%) a race or training session. The majority (n = 144, 73.8%) also reported experiencing only mild (,5 minutes and able to continue exercising) muscle cramps, whereas only (n = 38) 19.5% and (n = 18) 9.2% reported moderate (5-15 minutes and able to continue exercising) and severe (.15 minutes or had to stop exercising) muscle cramps, respectively. The average duration of cramps was 4.5 6 8.4 minutes (n = 181) and ranged from 0.1 to 60.0 minutes.
Although a variety of treatments were reported, the majority (n = 142, 65.7%) of the triathletes reported stretching the muscle to relieve the cramping. Only 5 (2.3%) of the athletes sought medical attention or had been confused or comatose as a result of experiencing muscle cramps, whereas 14 (6.5%) reported that EAMC was associated with dark urine. The majority of triathletes reported cramping during 3 or less of their last 10 races (n = 163, 84.5%) and their last 10 training sessions (n = 164, 86.8%).
Performance and Training History
The average career (adjusted P = 0.011), but not the previous 12 months, and Ironman PB times (adjusted P = 0.139) were significantly faster in the EAMC group (Table 2 ). There were no significant differences in PB times of the standard triathlon or any of the road running events between the 2 groups, indicating that both groups were similarly matched for previous performances. There were also no significant differences between the 2 groups for duration, distance, and speed of the cycling races in the 15 weeks before the 2007 Triathlon.
There were no significant differences in the training frequency, as well as the swim, cycle, run, or total distances and times spent training during the 15 weeks or 1 week before the Ironman events between the 2 groups (Table 3) . Although not significant (adjusted P = 0.128), the triathletes in the EAMC group cycled on average 1 km/h faster (27.8 6 5.7 km/h; n = 178) during the 15-week training period before the Ironman Triathlons compared with those in the CON group (26.8 6 5.9 km/h; n = 178).
Of note, in the 2007 questionnaire, the triathletes in the EAMC group reported significantly more fast or hard cycling and running training sessions during the 8-week period before the event than those in the CON group (Table 3 ).
Ironman Triathlon Performance
The self-reported prerace predicted an overall time for the EAMC group (P = 0.032; adjusted P = 0.090) and the predicted times for the swimming (P = 0.015, adjusted P = 0.019) and cycling (P = 0.008; adjusted P = 0.036) legs of the Ironman were significantly faster when compared with the CON group's predicted times (Table 4) . Subjects in the EAMC group achieved faster overall times (P = 0.008; adjusted P = 0.018) for the actual race than those in the CON group. The EAMC group also achieved faster times for the swimming leg (P = 0.016; adjusted P = 0.034) and cycling leg (P = 0.001; adjusted P = 0.004) during the race. There was no significant difference noted for the running leg of the Ironman for the predicted (P = 0.110) and actual (P = 0.322) times of the triathletes.
Although the triathletes in the EAMC group (27.7 6 2.9 km/h; n = 202) cycled significantly faster than those in the CON group (26.7 6 2.5 km/h; n = 205; P , 0.001; P value adjusted for sex = 0.002), there were no significant differences between the EAMC (102.5 6 22.4%, n = 167) and the CON (106.1 6 42.9%, n = 168) groups when the actual Ironman Triathlon cycle speed was expressed relative to the training cycling speed during the 15 weeks before the events (P = 0.344; P value adjusted for sex = 0.324). Similarly, there were also no significant differences between the EAMC (113.8 6 14.5%; n = 46) and the CON (113.7 6 10.4%, n = 46) groups when the actual 2007 Ironman Triathlon cycle speed was expressed relative to 15 weeks before the event cycling PB speed (P = 0.998). 
Family History of Exercise-Associated Muscle Cramps and Other Medical History
Significantly more triathletes in the EAMC group (36.6%; n = 202) reported a family history of EAMC when compared with those in the CON group (16.4%; n = 208; odds ratio, 3.0; 95% confidence interval, 1.9-4.7; P , 0.001). Interestingly, 68.9% (n = 62) and 69.5% (n = 32) of the triathletes in the EAMC and CON groups, respectively, reported that male (father and/or brother) biological relatives had experienced muscle cramps during exercise.
Flexibility Training
There were no significant differences between the 2 groups with respect to the total duration of stretching (P = 0.706), stretching before (P = 0.380) or after (P = 0.137) exercise sessions, and any of the muscle groups that were stretched (Table 5 ). Significantly more triathletes in the CON group reported stretching during exercise sessions (P = 0.026) than those in the EAMC group.
Regression Analysis: Factors Associated With a History of Exercise-Associated Muscle Cramps in Triathletes
The significant independent factors associated with a self-reported history of EAMC in Ironman triathletes were height (P = 0.003), an overall finishing time for the 2006 or 2007 Ironman Triathlon (P = 0.043), a history of tendon and/or ligament injuries (P = 0.022), and a family history of EAMC (P = 0.001) ( Table 6 ). There was a strong correlation between Ironman PB times and overall finishing time for the 2006 or 2007 Ironman Triathlon (r = 0.762; n = 180; P . 0.001). In addition, there was also a positive correlation between age and overall finishing times (r = 0.234; n = 373; P . 0.001), with older athletes completing the event in slower times. Because of the relative small sample size of the PB data, the overall finishing times and age were used in the analysis as a proxy for their PBs.
DISCUSSION
The main findings from this study were that independent factors that were associated with a self-reported history of EAMC in Ironman triathletes were an overall faster finishing time for the Ironman Triathlon, a history of tendon and/or ligament injuries, a family history of EAMC, and an increased height. To our knowledge, this is one of the largest casecontrol studies investigating factors that are associated with a self-reported history of EAMC in endurance athletes.
The first novel finding of this study was that triathletes with a self-reported history of EAMC had an overall faster finishing time for the Ironman Triathlon compared with those in the CON group. The obvious confounding variable that could account for this finding is that triathletes in the EAMC group were the better athletes (higher caliber athletes). However, except for their Ironman career PB times, an indepth analysis of career and recent PB times for triathlon and road running events showed that there were no significant differences between these groups of athletes. This indicates that both groups were evenly matched for ability in their endurance race career. Furthermore, the 2 groups were also similarly matched with respect to their training frequencies, times, and distances leading up to the event. However, the EAMC group did report higher intensity levels during their training sessions compared with the CON group during the 8 weeks before the event (only 2007 data). It therefore seems that both groups were similarly matched in athletic ability and in training. A faster finishing time in the race therefore indicates that the triathletes with a history of EAMC competed at a faster pace, and therefore higher relative exercise intensity, compared with those in the CON group. Data in support of this observation are that the triathletes in the EAMC group also predicted faster racing times (data obtained before the event at the time of registration) and then subsequently achieved the faster finishing times compared with those in the CON group. This was most significantly noted in the swimming and cycling legs, and even though the running section was not found to be significant, the times reported for both predicted and actual overall race times were also faster in the EAMC group. It therefore seems that despite similar athletic ability and training, triathletes with a history of EAMC predicted competed at a faster pace. This type of triathlete would be competing at a higher relative exercise intensity, which could increase the risk for developing muscle fatigue. This finding has been confirmed in a recent prospective cohort study in 210 triathletes. 15 In this study, the development of EAMC during an Ironman Triathlon was associated with faster predicted and faster actual race times, despite being similarly matched for preparation and performance histories to a noncramping control group. 15 The second novel finding of this study was the association between a history of tendon and/or ligament injuries and a history of EAMC. Injury as a possible risk factor for EAMC has not been reported, and there is no definitive explanation for this finding. However, it has recently been suggested that soft tissue injury could perhaps be a trigger for an increased neuromuscular excitability in muscles leading to EAMC 10 or that previously injured areas, which are weaker, may be susceptible to the development of premature fatigue. Previous injury could disrupt normal afferent and efferent neuromuscular pathways, which may result in an increased reflex alpha motor activity, possibly leading to EAMC in these areas. A limitation of this study is that the timing of the past injury in relation to the onset of EAMC was not recorded. This area does require further investigation.
The third novel finding of this study was that a positive family history for EAMC was associated with a history of EAMC. It was of interest to note that there was a significant family history of EAMC on the male side of the family. These observations suggest that there may be a genetic risk factor for the development of EAMC, and this has also been recently suggested. 10 This is also an area that would require further investigation.
The final novel finding of this study was that triathletes with a self-reported history of EAMC were taller. This has not Values are expressed as average 6 SD, with the number of subjects (n) with nonmissing data in parentheses. *Covaried for sex. †The totals are the sum of the swim, cycle and run disciplines. ‡Data from only the 2007 questionnaires. EAMC, exercise-associated muscle cramping.
been reported in any previous studies. In another study, increased body mass index but not increased height was reported as a possible risk factor for EAMC. 4 There is no apparent explanation for increased height to be a factor for EAMC. It could be speculated that this may be as a result of biomechanical differences during running or cycling or that this may be linked to genetic factors that are related to height. Increased height as a true risk factor for EAMC requires further investigation.
The descriptive data from the group of triathletes with a history of EAMC also showed some interesting observations. Triathletes with a history of EAMC reported that cramping occurred during any 1 of the 3 disciplines, were mild in nature, and were relieved most often by passive stretching. Cramping was confined to exercising muscle groups and was not generalized in its distribution, and most triathletes reported cramping in lower body exercising muscle groups (calves, hamstrings, quadriceps, and feet). These data support the observation that EAMC occur in localized muscle areas and not generally as with systemic abnormalities, such as dehydration or electrolyte depletion. 4, 11 Shorter daily stretching and irregular stretching habits have previously been suggested as factors associated with the development of EAMC. 4, 16 However, findings in this study did not support this, although triathletes in the CON group reported an increased stretching during exercise sessions compared with those in the EAMC group. Flexibility training histories of the triathletes in both groups were similar. Other previously reported risk factors for the development of EAMC, such as dehydration and electrolyte disturbances, were not investigated in this study. These risk factors have been well studied 2, 15, 17, 18 in prospective cohort studies, where it has consistently been shown that neither dehydration (as measured by prerace and postrace body weight changes) nor serum electrolyte concentrations were associated with the development of EAMC.
This case-control study was undertaken as a field study, where the main tool for obtaining the data was a questionnaire. Therefore, this study has inherent limitations. First, subjects were recruited at registration 3 days before the event, were selfselected, and therefore do not necessarily represent all Ironman triathletes. However, as the main aim was to compare triathletes with a history of EAMC with those with no history, it was important to recruit similar numbers of subjects in each group, and this was achieved.
A second limitation of this study was the use of a questionnaire to obtain data. Although a previously validated questionnaire was used, data collected in this manner relies on Values are expressed as average 6 SD or a frequency, with the number of subjects (n) with nonmissing data in parentheses. *Covaried for sex. †The total weekly stretching time (min/wk) was calculated as duration of stretch (minutes) 3 number of times each muscle group was stretched per day (number) 3 stretch sessions per day (number) 3 days of stretching per week (number).
EAMC, exercise-associated muscle cramping; ND, not determined.
recall. Recall bias is therefore an inherent limitation of this study design. However, it is important to point out that these athletes are usually very familiar with their physiology and their medical history because the nature of this event requires an in-depth analysis and understanding of the physiological demands of the sport. Furthermore, it is likely that any recall bias would be equally applicable to each of the 2 groups. However, the results have to be interpreted with possible recall bias in mind.
A third limitation of this study design is that no causeeffect relationship can be determined from these results. Results have to be interpreted purely as associations, where one variable may have caused an effect, could have occurred as a result of an effect, or 2 variables may have been related through another variable. Once again, the results of this study have to be interpreted with this limitation in mind.
This study design also has some inherent strengths. First, it is novel and is, to our knowledge, the largest study of this nature in endurance athletes. There were similar numbers of cases and controls, and a large number of variables could be studied. Because of the large sample sizes, statistical power was sufficient to allow for the in-depth analysis of the variables (adjusting for variables) and performing a regression analysis to determine independent variables. Finally, it is important to note that descriptive studies, such as this, are very important to identify novel factors that may be associated with a condition. Further cause-effect relationships can then be studied using a prospective cohort or intervention study designs.
In summary, novel independent factors associated with a self-reported history of EAMC in Ironman triathletes were an overall faster finishing time for the Ironman Triathlon, a history of tendon and/or ligament injuries, a family history of EAMC, and an increased height. The nature of the study methodology used does not allow us to conclude that these factors are causally related to EAMC in triathletes. Further scientific studies are needed to determine this causal relationship. 
